Meeting the numbers is no longer enough: Nasdaq's discretionary listing rule a year on
Since December 2025 Nasdaq has been able to deny an initial listing to a company that meets every numerical standard. The eight factors it weighs, and what an applicant can do about them.
A year ago a company that met Nasdaq’s numerical listing standards could expect to be listed. Since Dec. 19, 2025, that has not been a safe assumption. Interpretive rule IM-5101-3 gives the exchange what it calls limited discretion to deny an initial listing to a company that satisfies every stated requirement.
Why Nasdaq asked for it
In the autumn of 2025 the SEC suspended trading in a series of recently listed small-cap stocks over concerns about manipulation. Nasdaq’s filing listed more than a dozen such orders between late September and early December.
The exchange’s difficulty was legal. Its existing discretion under Rule 5101 reached a company that had itself engaged in misconduct, or one associated with a person who had a regulatory history. It did not reach a company whose stock was likely to be manipulated by unaffiliated third parties. A denial on that ground could be set aside by the SEC as inconsistent with Nasdaq’s own rules. IM-5101-3 closed the gap. Nasdaq filed it on Dec. 12, 2025 and it took effect a week later, including for companies already in the application process.
What the exchange looks at
The rule lists factors. None decides the matter alone, and the list is not exclusive. Gunderson Dettmer’s summary sets out eight:
- where the company is located, including the legal remedies available to U.S. shareholders and whether due diligence there is feasible;
- whether a person or entity has substantial influence over the company, and where that party is;
- whether the expected public float and distribution of shares, judged by the allocations of the underwriter and brokers and by their prior deals, raise liquidity or concentration concerns;
- the history of key advisors, including past regulatory reviews and whether their earlier deals later showed volatile or concerning trading;
- whether management and the board are familiar with U.S. public company requirements;
- any FINRA, SEC or other regulatory referrals involving the company or its advisors;
- a current or recent going-concern opinion from the auditor;
- any other concern about the integrity of the board, management, significant shareholders or advisors.
The word that recurs is advisors. The listing decision now turns in part on the track record of the underwriter, the auditor and counsel, measured by what happened to their previous clients’ stocks after listing.
The effect on deal flow
One practitioner tally counted 23 small-cap IPOs in the fourth quarter of 2025 and 5 in the first quarter of 2026, and attributed the fall to this rule, with a small recovery in the second quarter. The numbers are one firm’s count and should be read as an indication of scale.
Nasdaq followed with a companion rule. IM-5101-4, approved by the SEC on June 3, 2026, allows the exchange to delist a security after an SEC trading suspension where it finds delisting to be in the public interest.
What an applicant can do
The rule is discretionary, which makes it harder to plan for than a number. Four steps follow from the factors.
Choose advisors with the rule in mind. An issuer should ask a prospective underwriter and auditor how their recent small-cap listings have traded and whether any has been the subject of a trading suspension or a regulatory referral. Those are questions the rule directs the exchange to consider.
Broaden the shareholder base before applying. A float held by a few accounts is the pattern the liquidity and concentration factor describes. A company that has raised capital from a wide group of holders through an earlier exempt offering arrives with a better answer.
Document the distribution. Because the exchange judges concentration by allocations, an applicant should know who is being allocated shares in the offering and be able to show it.
Address a going-concern opinion directly. The factor asks for the company’s plan, so the application should contain one.
If the answer is no
The rule provides a process. Nasdaq staff must issue a written determination explaining a denial. The company may request review by a Hearings Panel within seven calendar days. It must also announce the denial publicly within four business days, with the specific grounds.
That last requirement gives applicants a strong reason to withdraw before a formal denial, which means few decisions are likely to be published and the standard will be worked out largely in discussions between listing staff and counsel.
Sponsor’s view
From Andy Altahawi, Adamson Brothers Corp., the sponsor of this publication. I understand why the exchange wanted this authority. The trading in some of last year’s small listings did real damage to investors and to every legitimate small issuer that came after. The cost is predictability. A company can now meet every published standard and still not know whether it will be listed, and the only protection is to arrive with advisors, shareholders and a distribution plan that need no explaining.
Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.